Lifecore Biomedical, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
514766104
SEDOL
2517058
CIK
0001005286
www.lifecore.com
LEI:
©
FIGI: BBG000G1FS10
LFCR
Lifecore Biomedical, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Drug Manufacturers - Specialty & Generic
AI
PROFILER
NAME
Lifecore Biomedical, Inc.
ISIN
US5147661046
TICKER
LFCR
MIC
XNAS
REUTERS
LFCR.OQ
BLOOMBERG
LFCR US
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
GIF DE 728x90
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Fr., 27.09.2024       Lifecore Biomedical
US5147661046

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ: LFCR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissio...
weiterlesen
Lifecore Biomedical
Research & Analysen Termsheet Terminal
Permalink
Do., 26.09.2024       Lifecore Biomedical
US5147661046

The Law Offices of Frank R. Cruz reminds investors of the upcoming September 27, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) securities between October 7, 2020 and March 19, 2024, inclusive (the “Class Period”). I...
weiterlesen
Lifecore Biomedical
Research & Analysen Termsheet Terminal
Permalink
Mo., 26.08.2024       Lifecore Biomedical
US5147661046

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Minnesota on behalf of those who acquired Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) securities during the period of October 7, 2020 to March 19, 2024, inclusive (“the Class Per...
weiterlesen
Lifecore Biomedical
Research & Analysen Termsheet Terminal
Permalink
Mo., 12.08.2024       Lifecore Biomedical
US5147661046

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ: LFCR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for a...
weiterlesen
Lifecore Biomedical
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Lifecore Biomedical
US5147661046

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Lifecore Biomedical, Inc. (NASDAQ: LFCR) securities between October 7, 2020 and March 19, 2024. Lifecore operates as an integrated contract development and manufacturing organization in the U.S. and inter...
weiterlesen
Lifecore Biomedical
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S